Becker's ASC

Author's posts

5 factors that will make or break ASCs

As operation costs skyrocket and reimbursements stagnate, ASCs are facing huge challenges to maintaining profitability. Here are five factors that can make or break ASCs in the coming years, according to seven ASC leaders. 

The Surgery Center of Pottsville to close

The Surgery Center of Pottsville (Pa.) is closing on June 28 after 17 years in operation.

Gastroenterologist wealth: 3 report takeaways

Gastroenterology is the sixth wealthiest speciality, according to Medscape’s Physician Wealth & Debt Report 2022.

What private practice physicians need to know about prior authorization

Prior authorization is a big part of private practice physicians’ jobs, but it’s among the least popular parts of healthcare for providers of all kinds. The good news: There are signs that reform is gaining momentum.

Private equity & ASCs: 4 updates in the last 14 days

Four updates from private equity companies from the last 14 days:

ASCs to see 25% surgery volume growth by 2032: 5 stats 

ASC surgery volume is projected to grow 25 percent in the next decade, according to an analysis from Sg2 Healthcare Intelligence, a Vizient company focused on market analytics and insights. 

FTC targeting healthcare private equity deals: What ASCs need to know

The Federal Trade Commission has taken aim against a private-equity firms’ healthcare deal in a move regulators say could spell trouble for other healthcare agreements the agency deems anticompetitive,  The Wall Street Journal reported recently.

$100M Georgia project to include Northside ASC

Atlanta-based Northside Hospital health system is building a new outpatient facility with an ASC in Snellville, Ga., What Now Atlanta reported June 17. 

ASC market value to reach $35.6B by 2028

By 2028, the ASC market is projected to reach over $35.6 billion, a study published June 17 by Coherent Market Insight reports.

Physicians’ bad investments, per Medscape 

Thirty percent of specialist physicians invested in a stock or company that turned out badly, according to Medscape’s “Physician Wealth & Debt Report 2022.”